✦ LIBER ✦

Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells

✍ Scribed by Caccamo, A E; Scaltriti, M; Caporali, A; D'Arca, D; Corti, A; Corvetta, D; Sala, A; Bettuzzi, S

Book ID: 110016805
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 226 KB
Volume: 12
Category: Article
ISSN: 1350-9047
DOI: 10.1038/sj.cdd.4401491

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thapsigargin, a Ca2+-ATPase inhibitor, d

Thapsigargin, a Ca2+-ATPase inhibitor, depletes the intracellular Ca2+ pool and induces apoptosis in human hepatoma cells.

✍ Ayumi Tsukamoto; Yoshiyasu Kaneko 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Activation of a Ca2+-permeable cation ch

Activation of a Ca2+-permeable cation channel by two different inducers of apoptosis in a human prostatic cancer cell line

✍ Andrés A. Gutiérrez; Juan Manuel Arias; Lucía García; Jaime Mas-Oliva; Agustín G 📂 Article 📅 1999 🏛 Cambridge University Press 🌐 English ⚖ 771 KB

Role of intracellular Ca2+signal in the

Role of intracellular Ca2+signal in the ascorbate-induced apoptosis in a human hepatoma cell line

✍ Yong Soo Lee 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 727 KB

ChemInform Abstract: HY251 (I), a Novel

ChemInform Abstract: HY251 (I), a Novel Decahydrocyclopenta[a]indene Analogue, from Aralia continentalis Induces Apoptosis via Down-Regulation of AR Expression in Human Prostate Cancer LNCaP Cells.

✍ Ha Lim Oh; Chul-Hoon Lee 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 20 KB 👁 1 views

The novel heterodinucleoside dimer 5-FdU

The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145

✍ R.M.C. Cattaneo-Pangrazzi; H. Schott; R.A. Schwendener 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1-␤-D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell